Skip to main content
Clinical Trials/NCT03273244
NCT03273244
Completed
Not Applicable

Towards a Better Understanding of What Palliative Sedated Patients Experience: Linking Numbers to Experiences

Vrije Universiteit Brussel2 sites in 1 country12 target enrollmentMay 12, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Palliative Sedation
Sponsor
Vrije Universiteit Brussel
Enrollment
12
Locations
2
Primary Endpoint
Level of pain and discomfort
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Background. In case of untreatable suffering at the end of life, palliative sedation may be chosen to assure comfort by reducing the patient's level of consciousness. An important question here is whether such sedated patients are certainly completely free of pain. Because these patients cannot communicate anymore, caregivers have to rely on observation to assess the patient's comfort. Recently however, more sophisticated techniques from the neurosciences (fMRI, EEG) have shown that sometimes consciousness and pain is undetectable with these traditional behavioral methods.

Therefore there is an urgent need for a more reliable way of assessment by combining existing observational scales, subjective assessments of caregivers and family and neuroimaging techniques.

Aim. The aim of this study is to better understand how unconscious palliative sedated patients experience the last days of their life and to find out if they are really free of pain.

Methods In this study the investigators will observe 40 patients starting with initiation of palliative sedation until death.

Assessment of comfort based on behavioural observations will be related with the results from a NeuroSense monitor, an EEG-based brain monitor used for evaluation of the adequacy of anesthesia and sedation in the operating room and an ECG-based Analgesia Nociception Index (ANI) monitor, which informs about the comfort or discomfort condition of the organism, based on the parasympathetic tone (including calculation of ANI). Additionally, the researchers will investigate whether changes of these measures can be linked to changes in the patients' experience as observed by caregivers and relatives, especially in the last moments of life. An innovative and challenging aspect of this study is its qualitative approach, implying all the different types of data will be used to link "objective" and "subjective" data to achieve a holistic understanding of the study topics.

The following data will be collected:

  • assessment of pain/comfort by the patients themselves before loss of consciousness due to deep continuous sedation (if possible) by scoring a Visual Analogue Scale (VAS)
  • brain function monitoring (NeuroSense monitor)
  • monitoring of parasympathetic tone (ANI monitor)
  • assessment by caregivers on 3 VAS scales (different scales or 3 different caregivers?)
  • relatives' perception of the quality of the dying process on 3 VAS scales (idem)
  • assessment by 2 trained investigators using observational scales
  • observation: video and audio registration
Registry
clinicaltrials.gov
Start Date
May 12, 2017
End Date
September 30, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Stefaan Six

Principal Investigator

Vrije Universiteit Brussel

Eligibility Criteria

Inclusion Criteria

  • Patients may be included if they are considered by their treating physician as:
  • in their last week of life
  • in conditions that might, when not treated, cause high levels of distress
  • unable to communicate

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Level of pain and discomfort

Time Frame: From date of enrollment until the date of death, on average less than 1 week.

Level of pain and discomfort as measured by an ANI-monitor and expressed by the analgesia nociception index (ANI). The ANI is based on HRV (heart rate variability).

Level of awareness

Time Frame: From date of enrollment until the date of death, on average less than 1 week.

Level of awareness as measured by a NeuroSense monitor and expressed as the WAVcns index (Wavelet-based Anesthetic Value for Central Nervous System). The WAVcns is based on cortical EEG.

Secondary Outcomes

  • Pain(From date of enrollment until the date of death (on average less than 1 week), during visit, once a day.)
  • Awareness(From date of enrollment until the date of death (on average less than 1 week), during visit, once a day.)
  • Communication(From date of enrollment until the date of death (on average less than 1 week), during visit, once a day.)

Study Sites (2)

Loading locations...

Similar Trials